Thromb Haemost 1979; 42(05): 1523-1528
DOI: 10.1055/s-0038-1657054
Original Article
Schattauer GmbH Stuttgart

Acquired von Willebrand’s Syndrome during Autoimmune Disorder

Javier Pizzuto
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Raul Ambriz
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Maria de la Paz Reyna
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Luis M Monrroy
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Manuel R Morales
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Agustin Aviles
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Guillermo Conte
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Ruben Enriquez
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
› Author Affiliations
Further Information

Publication History

Received 03 July 1979

Accepted 10 July 1979

Publication Date:
23 August 2018 (online)

Summary

A case with evidence of acquired von Willebrand’s syndrome associated with systemic lupus erythmatosus and Sjögren’s syndrome is described. The patient, who had no family history of bleeding, presented a haemorrhagic diathesis of recent origin, the bleeding time was prolonged, procoagulant Factor-VIII and von Willebrand factor levels were low and platelet aggregation was decreased with different concentrations of Ristocetin®.

No improvement was seen after the tranfusion of cryoprecipitates, and there was no increase in procoagulant Factor-VIII.

Clinical improvement resulted after treatment with corticosteroids, and later, the laboratory abnormalities characteristic of von Willebrand’s disease became normal. The level of procoagulant factor-VIII reached the very high level of 810%.

 
  • References

  • 1 Allain JP, Cooper HA, Wagner RH, Brinkhous KM. 1975; A new reagent for assay of von Willebrand factor and platelet aggregating factor. Journal of Laboratory and Clinical Medicine 85: 318
  • 2 GRUPO CLAHT: Técnicas de Hemostasia y Trombosis. 1975. ed Miguel Pavlovsky; Buenos Aires, Argentina:
  • 3 Handin RI, Martin V, Molonney WC. 1976; Antibody-induced von Willebrand’s disease: A newly defined inhibitor syndrome. Blood 48: 393
  • 4 Hoyer LW. 1976; Von Willebrand’s disease. Progress in Hemostasis and Thrombosis 3: 231
  • 5 Ingram GI C, Kingston PJ, Leslie J, Bowie EJ W. 1971; Four cases of acquired von Willebrand’s syndrome. British Journal of Haematology 21: 189
  • 6 Ingram GI C, Prentice CR M, Forbes CD, Leslie J. 1973; Low factor - VIII like antigen in acquired von Willibrand’s syndrome and response to treatment. British Journal of Haematology 25: 137
  • 7 Joist JH, Cowan JF, Zimmermann TS. 1978; Acquired von Willebrand’s disease. Evidence for a quantitative and qualitative Factor VIII disorder The New England Journal of Medicine 298: 988
  • 8 Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantanoni J, Green D, Hampton JW, Hilgartner MW, Lazarson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Schulman NR, VAN EYS J. 1975; A more uniform measurement of factor VIII inhibitors. Thrombosis et Diathesis Haemorrhagica 34: 869
  • 9 Leone G, Pola P, Gurrera G, Bizzi B. 1974; Syndrome di von Willebrand acquisita in corso di malattia disreattiva. Acquired von Willebrand’s syndrome during collagen disorder. Haematologica (Roma) 59: 212
  • 10 Mant MJ, Hirsh J, Gauldie J, Bienenstock J, Pineo GF, Luke KH. 1973; Von Willebrand’s syndrome as an acquired bleeding disorder in association with a monoclonal gammopathy. Blood 42: 429
  • 11 Meyer D, Jenkins CS P, Dreyfus MD, Fressinaud E, Larrieu MJ. 1974; Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor-VIII activity. British Journal of Haematology 28: 519
  • 12 Poole-Wilson PA. 1972; Acquired von Willebrand’s syndrome and systemic lupus erythematosus. Proceedings of the Royal Society of Medicine 65: 561
  • 13 Simone JV, Cornet JA, Abildgaard CF. 1968; Acquired von Willebrand’s syndrome in systemic lupus erythematosus. Blood 31: 806
  • 14 S^Ableforth P, Tamagnini GL, DORMANDY KM. 1976; Acquired von Willebrand syndrome with inhibitors both to Factor-VIII clotting activity and ristocetin - induced aggregation. British Journal of Haematology 33: 565
  • 15 Veltkamp JJ, Stevens P, Plass MV D, Loeliger EA. 1970; Production sit of bleeding factor (acquired morbus von Willebrand). Thrombosis et Diathesis Haemorrhagica 23: 412
  • 16 Wautier JL, Levy-Toledano S, Caen JP. 1976; Acquired von Willebrand’s syndrome and Thrombopathy in a patient with chronic lymphocytic leukaemia. Scandinavian Journal of Haematology 16: 128
  • 17 Zettervall O, Nilsson IM. 1978; Acquired von Willebrand’s disease caused by a monoclonal antibody, Acta Medica Scandinavica. 204: 521